Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $21,403,000 | $21,960,000 | $23,565,000 | $20,975,353 |
| % Growth | -2.5% | -6.8% | 12.3% | – |
| Cost of Goods Sold | $12,728,000 | $11,506,000 | $13,461,000 | $11,736,316 |
| Gross Profit | $8,675,000 | $10,454,000 | $10,104,000 | $9,239,038 |
| % Margin | 40.5% | 47.6% | 42.9% | 44% |
| R&D Expenses | $0 | $0 | $162,000 | $0 |
| G&A Expenses | $2,058,000 | $1,895,000 | $1,776,000 | $0 |
| SG&A Expenses | $5,622,000 | $5,370,000 | $5,102,000 | $4,958,839 |
| Sales & Mktg Exp. | $3,564,000 | $3,475,000 | $3,326,000 | $0 |
| Other Operating Expenses | $0 | $5,073,000 | $0 | $0 |
| Operating Expenses | $5,622,000 | $10,443,000 | $6,606,000 | $4,958,839 |
| Operating Income | $3,053,000 | $11,000 | $3,498,000 | $4,280,198 |
| % Margin | 14.3% | 0.1% | 14.8% | 20.4% |
| Other Income/Exp. Net | -$6,361,000 | $3,174,000 | -$2,095,000 | -$1,394,984 |
| Pre-Tax Income | -$3,308,000 | $3,185,000 | $1,403,000 | $2,885,215 |
| Tax Expense | $163,000 | $797,000 | $358,000 | $589,346 |
| Net Income | -$3,471,000 | $2,388,000 | $1,045,000 | $2,295,869 |
| % Margin | -16.2% | 10.9% | 4.4% | 10.9% |
| EPS | -7.82 | 5.38 | 2.35 | 5.09 |
| % Growth | -245.4% | 128.9% | -53.8% | – |
| EPS Diluted | -7.82 | 5.38 | 2.35 | 5.09 |
| Weighted Avg Shares Out | 444,100 | 444,114 | 444,125 | 444,300 |
| Weighted Avg Shares Out Dil | 444,100 | 444,100 | 444,100 | 444,300 |
| Supplemental Information | – | – | – | – |
| Interest Income | $186,000 | $0 | $583,655 | $464,333 |
| Interest Expense | $888,000 | $652,000 | $620,128 | $951,486 |
| Depreciation & Amortization | $1,050,000 | $1,039,000 | $465,000 | $936,603 |
| EBITDA | -$2,258,000 | $4,935,000 | $5,857,000 | $5,216,802 |
| % Margin | -10.5% | 22.5% | 24.9% | 24.9% |